{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:08:21Z","timestamp":1794553701820,"version":"4.9.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,8]],"date-time":"2027-09-08T00:00:00Z","timestamp":1820361600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-NTF-22-972518"],"award-info":[{"award-number":["AARG-NTF-22-972518"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["CPRIT-RP230419"],"award-info":[{"award-number":["CPRIT-RP230419"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R16GM146696"],"award-info":[{"award-number":["R16GM146696"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014108","name":"University of Texas Rio Grande Valley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drudis.2026.104788","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:30:26Z","timestamp":1787848226000},"page":"104788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic reprogramming and drug resistance in hepatocellular carcinoma: The emerging role of SREBP2-driven cholesterol metabolism"],"prefix":"10.1016","volume":"31","author":[{"given":"Veerababu","family":"Nagati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Tenugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-8668","authenticated-orcid":false,"given":"Manish K.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104788_b0005","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.drudis.2026.104788_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23850","article-title":"Beta-caryophyllene attenuates experimental hepatocellular carcinoma through downregulation of oxidative stress and inflammation","volume":"38","author":"Ahmad","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.drudis.2026.104788_b0015","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/cancers12061576","article-title":"Sorafenib resistance in hepatocellular carcinoma: the relevance of genetic heterogeneity","volume":"12","author":"Cabral","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2026.104788_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","article-title":"Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors","volume":"50","author":"M\u00e9ndez-Blanco","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104788_b0025","article-title":"Insights into Sorafenib resistance in hepatocellular carcinoma: mechanisms and therapeutic aspects","volume":"212","author":"Eman","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.drudis.2026.104788_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4846","article-title":"Cost-effectiveness of atezolizumab plus bevacizumab vs sorafenib for patients with unresectable or metastatic hepatocellular carcinoma","volume":"4","author":"Zhang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.drudis.2026.104788_b0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12962-023-00435-x","article-title":"Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China","volume":"21","author":"Gong","year":"2023","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.drudis.2026.104788_b0040","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2026.104788_b0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1053\/j.gastro.2011.03.006","article-title":"Targeted therapies for hepatocellular carcinoma","volume":"140","author":"Villanueva","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2026.104788_b0050","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104788_b0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.37349\/edd.2022.00003","article-title":"Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma","volume":"1","author":"Escobedo-Calvario","year":"2022","journal-title":"Explor Dig Dis"},{"key":"10.1016\/j.drudis.2026.104788_b0060","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1073\/pnas.94.24.12975","article-title":"Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins","volume":"94","author":"Swinnen","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104788_b0065","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/sj.onc.1203889","article-title":"Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway","volume":"19","author":"Swinnen","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104788_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107037","article-title":"SIRT1\/SREBPs-mediated regulation of lipid metabolism","volume":"199","author":"Shen","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2026.104788_b0075","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fonc.2020.01510","article-title":"Targeting SREBP-2-regulated mevalonate metabolism for cancer therapy","volume":"10","author":"Xue","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104788_b0080","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/cas.14006","article-title":"Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer","volume":"110","author":"Kuwano","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s44178-023-00039-8","article-title":"Holistic anti-tumor resistance mechanism of YBX1 and its potential as a chemoresistance target in pancreatic ductal adenocarcinoma","volume":"2","author":"Li","year":"2023","journal-title":"Holist Integr Oncol"},{"key":"10.1016\/j.drudis.2026.104788_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116021","article-title":"Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: a comprehensive review","volume":"170","author":"Wang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104788_b0095","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3724\/abbs.2023122","article-title":"SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR\/IL-1\u03b2 pathway","volume":"55","author":"Fan","year":"2023","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.drudis.2026.104788_b0100","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-23-2889","article-title":"SPARC stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma","volume":"84","author":"Wan","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104788_b0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","volume":"69","author":"Che","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2026.104788_b0115","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2026.104788_b0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology \u2013 divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.drudis.2026.104788_b0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104788_b0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2010.06.004","article-title":"Sterol metabolism and SREBP activation","volume":"501","author":"Sato","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.drudis.2026.104788_b0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Sorrentino","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2026.104788_b0140","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI119746","article-title":"Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene","volume":"100","author":"Shimano","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2026.104788_b0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/cas.15449","article-title":"SREBF2-STARD4 axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis","volume":"114","author":"Yue","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","article-title":"Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes","volume":"40","author":"Shimano","year":"2001","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.drudis.2026.104788_b0155","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1194\/jlr.M300285-JLR200","article-title":"IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells: evidence that IDH1 may regulate lipogenesis in hepatic cells","volume":"44","author":"Shechter","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.drudis.2026.104788_b0160","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1073\/pnas.0700899104","article-title":"Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig","volume":"104","author":"Radhakrishnan","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104788_b0165","doi-asserted-by":"crossref","first-page":"52772","DOI":"10.1074\/jbc.M410302200","article-title":"Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs","volume":"279","author":"Adams","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104788_b0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2005.11.014","article-title":"Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake","volume":"3","author":"Gong","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2026.104788_b0175","doi-asserted-by":"crossref","first-page":"39308","DOI":"10.1074\/jbc.M608999200","article-title":"Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104788_b0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cmet.2012.06.014","article-title":"Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis","volume":"16","author":"Liu","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2026.104788_b0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0092-8674(94)90234-8","article-title":"SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis","volume":"77","author":"Wang","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104788_b0190","article-title":"Targeting SREBP-1-mediated lipogenesis as potential strategies for cancer","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104788_b0195","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1073\/pnas.95.9.4935","article-title":"Specificity in cholesterol regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein","volume":"95","author":"Athanikar","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104788_b0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","article-title":"Protein sensors for membrane sterols","volume":"124","author":"Goldstein","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104788_b0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2006.01.001","article-title":"The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients","volume":"189","author":"Durst","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.drudis.2026.104788_b0210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13046-022-02306-4","article-title":"Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma","volume":"41","author":"Li","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0215","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2026.104788_b0220","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1073\/pnas.90.24.11603","article-title":"SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element","volume":"90","author":"Hua","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104788_b0225","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104788_b0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.CCR-13-0122","article-title":"Molecular pathways: sterols and receptor signaling in cancer","volume":"20","author":"Gabitova","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0235","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cmet.2005.04.006","article-title":"Dual regulation of the LDL receptor\u2014some clarity and new questions","volume":"1","author":"Attie","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.drudis.2026.104788_b0240","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jhep.2017.10.018","article-title":"Statin use and the risk of hepatocellular carcinoma in patients at high risk: a nationwide nested case-control study","volume":"68","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.drudis.2026.104788_b0245","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MCG.0000000000001260","article-title":"Statin use is protective against hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a case-control study","volume":"54","author":"German","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.drudis.2026.104788_b0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stem.2023.11.011","article-title":"A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS","volume":"31","author":"Duan","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drudis.2026.104788_b0255","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1541-7786.MCR-19-0756","article-title":"Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance in breast cancer","volume":"17","author":"Sethunath","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0260","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","article-title":"Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104788_b0265","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional significance of cholesterol metabolism in cancer: from threat to treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104788_b0270","article-title":"ABCA1 deficiency causes tissue-specific dysregulation of the SREBP2 pathway in mice","volume":"1869","author":"Yamauchi","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.drudis.2026.104788_b0275","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol efflux pathways suppress inflammasome activation, NETosis, and atherogenesis","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2026.104788_b0280","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/ATVBAHA.112.301195","article-title":"ABCA1 mediates unfolding of apolipoprotein AI N terminus on the cell surface before lipidation and release of nascent high-density lipoprotein","volume":"33","author":"Wang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.drudis.2026.104788_b0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00041433-200502000-00005","article-title":"ATP-binding cassette transporter AI and its role in HDL formation","volume":"16","author":"Lee","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.drudis.2026.104788_b0290","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.coph.2012.06.012","article-title":"Oxysterol receptors, AKT and prostate cancer","volume":"12","author":"Dufour","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.drudis.2026.104788_b0295","doi-asserted-by":"crossref","first-page":"23742","DOI":"10.1074\/jbc.M102348200","article-title":"ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104788_b0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3892\/ol.2022.13469","article-title":"Roles of ABCA1 in cancer","volume":"24","author":"Wu","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.drudis.2026.104788_b0305","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2026.104788_b0310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.gde.2008.07.016","article-title":"Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors","volume":"18","author":"Hong","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.drudis.2026.104788_b0315","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1158\/2159-8290.CD-11-0102","article-title":"An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR\/AKT\/SREBP-1\/LDLR-dependent pathway","volume":"1","author":"Guo","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.drudis.2026.104788_b0320","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1158\/0008-5472.CAN-24-0970","article-title":"Targeting cholesterol biosynthesis with statins synergizes with AKT inhibitors in triple-negative breast cancer","volume":"84","author":"Hillis","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0325","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1042\/BCJ20160822","article-title":"Amino acid homeostasis and signalling in mammalian cells and organisms","volume":"474","author":"Br\u00f6er","year":"2017","journal-title":"Biochem J"},{"key":"10.1016\/j.drudis.2026.104788_b0330","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3413186","article-title":"Kangtaizhi granule alleviated nonalcoholic fatty liver disease in high\u2010fat diet\u2010fed rats and HepG2 cells via AMPK\/mTOR signaling pathway","volume":"2020","author":"Zhang","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.drudis.2026.104788_b0335","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tem.2010.01.001","article-title":"The Akt\u2013SREBP nexus: Cell signaling meets lipid metabolism","volume":"21","author":"Krycer","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.drudis.2026.104788_b0340","doi-asserted-by":"crossref","first-page":"689","DOI":"10.21037\/atm-22-2482","article-title":"CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT\/ERK signaling CXCR4 axis","volume":"10","author":"Xie","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.drudis.2026.104788_b0345","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/biomedicines9111639","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2026.104788_b0350","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104788_b0355","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/ijms19103127","article-title":"Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of sorafenib through suppression of cholesterol metabolism","volume":"19","author":"Kim","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0360","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1096\/fj.201802619RR","article-title":"Sorafenib kills liver cancer cells by disrupting SCD1\u2010mediated synthesis of monounsaturated fatty acids via the ATP\u2010AMPK\u2010mTOR\u2010SREBP1 signaling pathway","volume":"33","author":"Liu","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2026.104788_b0365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12931-023-02313-9","article-title":"TGF-\u03b21 promotes SCD1 expression via the PI3K-Akt-mTOR-SREBP1 signaling pathway in lung fibroblasts","volume":"24","author":"Zhou","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.drudis.2026.104788_b0370","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13046-025-03291-0","article-title":"TGF-\u03b2 induces cholesterol accumulation to regulate the secretion of tumor-derived extracellular vesicles","volume":"44","author":"Rodrigues-Junior","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0375","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.26698","article-title":"Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2026.104788_b0380","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/ijms22031272","article-title":"Fatty acids and a high-fat diet induce epithelial\u2013mesenchymal transition by activating TGF\u03b2 and \u03b2-catenin in liver cells","volume":"22","author":"Kwapisz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0385","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1080\/21655979.2022.2026550","article-title":"SREBP2 promotes the viability, proliferation, and migration and inhibits apoptosis in TGF-\u03b21-induced airway smooth muscle cells by regulating TLR2\/NF-\u03baB\/NFATc1\/ABCA1 regulatory network","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.drudis.2026.104788_b0390","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.3390\/ijms22115543","article-title":"Epithelial\u2013mesenchymal transition (EMT) induced by TGF-\u03b2 in hepatocellular carcinoma cells reprograms lipid metabolism","volume":"22","author":"Soukupova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0395","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/CM9.0000000000003144","article-title":"The switch triggering the invasion process: Lipid metabolism in the metastasis of hepatocellular carcinoma","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin Med J"},{"key":"10.1016\/j.drudis.2026.104788_b0400","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104788_b0405","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2026.104788_b0410","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bcp.2013.02.007","article-title":"Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK\u2013mTOR\u2013SREBP signaling pathway","volume":"85","author":"Quan","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2026.104788_b0415","doi-asserted-by":"crossref","first-page":"21022","DOI":"10.18632\/oncotarget.24781","article-title":"Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma","volume":"9","author":"Ogura","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104788_b0420","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrc.2016.76","article-title":"The interplay between cell signalling and the mevalonate pathway in cancer","volume":"16","author":"Mullen","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104788_b0425","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.3390\/ijms22168567","article-title":"Secretory NPC2 protein-mediated free cholesterol levels were correlated with the sorafenib response in hepatocellular carcinoma","volume":"22","author":"Suk","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0430","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-017-0490-8","article-title":"Pro-inflammation NF-\u03baB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells","volume":"36","author":"He","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0435","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/acs.jpcb.5b12337","article-title":"Effect of cholesterol on cellular uptake of cancer drugs pirarubicin and ellipticine","volume":"120","author":"Zhang","year":"2016","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.drudis.2026.104788_b0440","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104788_b0445","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jcp.22570","article-title":"Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib","volume":"226","author":"Irwin","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2026.104788_b0450","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1016\/j.febslet.2013.10.007","article-title":"Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells","volume":"587","author":"Xu","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.drudis.2026.104788_b0455","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1579054","article-title":"Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications","volume":"15","author":"Lagunas-Rangel","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104788_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102678","article-title":"Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment","volume":"62","author":"Zhao","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.drudis.2026.104788_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116974","article-title":"Cholesterol metabolism: a strategy for overcoming drug resistance in tumors","volume":"238","author":"Li","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2026.104788_b0470","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3390\/ph18111699","article-title":"Polyphyllin H reverses paclitaxel resistance in breast cancer by binding membrane cholesterol to inhibit both ABCB1 and ABCC3","volume":"18","author":"Ye","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2026.104788_b0475","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.acr.2014.10.004","article-title":"Lipid regulation of the ABCB1 and ABCG2 multidrug transporters","volume":"125","author":"Heged\u00fcs","year":"2015","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0480","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbalip.2015.12.007","article-title":"Cholesterol-dependent conformational changes of P-glycoprotein are detected by the 15D3 monoclonal antibody","volume":"1861","author":"Gutay-T\u00f3th","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.drudis.2026.104788_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217197","article-title":"YBX1 as a therapeutic target to suppress the LRP1-\u03b2-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer","volume":"602","author":"Li","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2026.104788_b0490","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/HEP.0000000000001392","article-title":"The MASTL\/YBX1\/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib resistance and tumor progression in HCC","volume":"83","author":"Liang","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2026.104788_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104439","article-title":"Transcription factor YBX1 orchestrates drug resistance and tumor progression in HCC","volume":"30","author":"Kwabiah","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104788_b0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2003.tb01344.x","article-title":"The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies","volume":"94","author":"Kuwano","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0505","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0510","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.semcdb.2004.01.002","article-title":"PI 3-kinase, Akt and cell survival","volume":"15","author":"Downward","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.drudis.2026.104788_b0515","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3727\/096504017X14886444100783","article-title":"Inhibition of MMP-2 expression enhances the antitumor effect of sorafenib in hepatocellular carcinoma by suppressing the PI3K\/AKT\/mTOR pathway","volume":"25","author":"Tan","year":"2017","journal-title":"Oncol Res"},{"key":"10.1016\/j.drudis.2026.104788_b0520","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/ijms22010224","article-title":"Y-box binding protein-1 promotes epithelial-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells","volume":"22","author":"Liao","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0525","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.3748\/wjg.v27.i28.4667","article-title":"Y-box binding protein 1 augments sorafenib resistance via the PI3K\/Akt signaling pathway in hepatocellular carcinoma","volume":"27","author":"Liu","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.drudis.2026.104788_b0530","doi-asserted-by":"crossref","first-page":"e3689","DOI":"10.1002\/jgm.3689","article-title":"YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT\/\u03b2-catenin axis","volume":"26","author":"Shi","year":"2024","journal-title":"J Gene Med"},{"key":"10.1016\/j.drudis.2026.104788_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166290","article-title":"TGF-\u03b2\/YB-1\/Atg7 axis promotes the proliferation of hepatic progenitor cells and liver fibrogenesis","volume":"1868","author":"Guo","year":"2022","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.drudis.2026.104788_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110864","article-title":"RRM2 promotes liver metastasis of pancreatic cancer by stabilizing YBX1 and activating the TGF-beta pathway","volume":"27","author":"Du","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.drudis.2026.104788_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.117064","article-title":"LINC00618 facilitates growth and metastasis of hepatocellular carcinoma via elevating cholesterol synthesis by promoting NSUN2-mediated SREBP2 m5C modification","volume":"285","author":"Li","year":"2024","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.drudis.2026.104788_b0550","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.7150\/ijbs.105798","article-title":"YBX1\/CD36 positive feedback loop-mediated lipid accumulation drives metabolic dysfunction-associated steatotic liver disease","volume":"21","author":"Zhang","year":"2025","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.drudis.2026.104788_b0555","article-title":"Tumor cell-derived CXCL2 potentiates neutrophil-mediated antitumor immunity by inhibiting cholesterol biosynthesis in hepatocellular carcinoma","volume":"13","author":"Liu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2026.104788_b0560","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/biomedicines14030545","article-title":"Computational repurposing and experimental validation of YBX1 inhibitors in hepatocellular carcinoma","volume":"14","author":"Karkoutly","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2026.104788_b0565","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.chembiol.2021.02.014","article-title":"Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer","volume":"28","author":"Tailor","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2026.104788_b0570","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-019-1884-7","article-title":"SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity","volume":"10","author":"Yin","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2026.104788_b0575","article-title":"New insights into the therapeutic potentials of statins in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104788_b0580","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13046-024-03142-4","article-title":"TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer","volume":"43","author":"Akman","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116207","article-title":"Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer","volume":"224","author":"Cao","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2026.104788_b0590","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1158\/0008-5472.CAN-21-2934","article-title":"Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma","volume":"82","author":"Mok","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0595","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41401-022-00984-6","article-title":"Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide","volume":"44","author":"Choo","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.drudis.2026.104788_b0600","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","article-title":"The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis","volume":"11","author":"Hong","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.drudis.2026.104788_b0605","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70132","article-title":"Proteolysis-targeting chimeras in cancer therapy: Targeted protein degradation for next-generation treatment","volume":"131","author":"Anaya","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.drudis.2026.104788_b0610","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chembiol.2009.07.007","article-title":"A small molecule that blocks fat synthesis by inhibiting the activation of SREBP","volume":"16","author":"Kamisuki","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.drudis.2026.104788_b0615","doi-asserted-by":"crossref","first-page":"F614","DOI":"10.1152\/ajprenal.00140.2016","article-title":"SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction","volume":"311","author":"Mustafa","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.drudis.2026.104788_b0620","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s12276-020-0430-0","article-title":"The cellular function of SCAP in metabolic signaling","volume":"52","author":"Lee","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104788_b0625","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jn\/134.6.1340","article-title":"The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells","volume":"134","author":"Casaschi","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.drudis.2026.104788_b0630","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.108.139626","article-title":"Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals","volume":"326","author":"Hawkins","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.drudis.2026.104788_b0635","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(25)00403-9","article-title":"Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial","volume":"405","author":"Yau","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2026.104788_b0640","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104788_b0645","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/bcr2769","article-title":"Anti-tumour activity of bisphosphonates in preclinical models of breast cancer","volume":"12","author":"Holen","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0650","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1158\/0008-5472.CAN-05-4061","article-title":"Breast cancer growth prevention by statins","volume":"66","author":"Campbell","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104788_b0655","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/ijc.32426","article-title":"Statin use and risk of liver cancer: evidence from two population\u2010based studies","volume":"146","author":"Tran","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.drudis.2026.104788_b0660","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/genes15010004","article-title":"Ezetimibe induces paraptosis through Niemann-Pick C1-like 1 inhibition of mammalian-target-of-rapamycin signaling in hepatocellular carcinoma cells","volume":"15","author":"Yin","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.drudis.2026.104788_b0665","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9840","article-title":"Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target","volume":"10","author":"Liu","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2026.104788_b0670","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/mc.23538","article-title":"LATS\u2010regulated nuclear\u2010cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial\u2013mesenchymal transition","volume":"62","author":"Zhang","year":"2023","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.drudis.2026.104788_b0675","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/hep.29018","article-title":"Inhibition of the sterol regulatory element-binding protein pathway suppresses hepatocellular carcinoma by repressing inflammation in mice","volume":"65","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2026.104788_b0680","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1074\/jbc.M115.656975","article-title":"Xanthohumol improves diet-induced obesity and fatty liver by suppressing sterol regulatory element-binding protein (SREBP) activation","volume":"290","author":"Miyata","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104788_b0685","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/1535370218760283","article-title":"SREBP2 contributes to cisplatin resistance in ovarian cancer cells","volume":"243","author":"Zheng","year":"2018","journal-title":"Exp Biol Med"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:21:36Z","timestamp":1790094096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626001935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":137,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1359644626001935"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104788","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming and drug resistance in hepatocellular carcinoma: The emerging role of SREBP2-driven cholesterol metabolism","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104788"}}